Following is a transcript of their remarks:
Vinay Prasad, MD: All right, I'm Dr. Vinay Prasad. I'm an associate professor and a practicing hematologist oncologist here at the University of California San Francisco. I'm joined via Zoom by two dear colleagues who are myeloma experts, Aaron Goodman, assistant professor at the University of California San Diego, an expert in bone marrow transplantation and hem malignancies, and Dr. Al-Ola Abdallah at the University of Kansas, also an expert in hematologic malignancies and bone marrow transplant. It's a pleasure to have you both here, sirs.
Well, let's get started. There is so much to talk about at this year's ASH annual meeting about myeloma. All our favorite drugs are there and some of the ones we don't like too much, and so let's get started.